...
机译:切除气管鳞状细胞癌的病理特征:基于59例分析的预后因素
Division of Thoracic Surgery Massachusetts General Hospital and Harvard Medical School 32 Fruit Street Blake 1570 Boston MA 02114 USA;
Division of Thoracic Surgery Massachusetts General Hospital and Harvard Medical School 32 Fruit Street Blake 1570 Boston MA 02114 USA;
Department of Pathology Massachusetts General Hospital and Harvard Medical School Boston MA USA;
Division of Thoracic Surgery Massachusetts General Hospital and Harvard Medical School 32 Fruit Street Blake 1570 Boston MA 02114 USA;
Division of Thoracic Surgery Massachusetts General Hospital and Harvard Medical School 32 Fruit Street Blake 1570 Boston MA 02114 USA;
Division of Thoracic Surgery Massachusetts General Hospital and Harvard Medical School 32 Fruit Street Blake 1570 Boston MA 02114 USA;
Department of Pathology Massachusetts General Hospital and Harvard Medical School Boston MA USA;
Trachea; Squamous cell carcinoma; Airway resection; Pathologic staging; Histologic features of invasion;
机译:切除气管鳞状细胞癌的病理特征:基于59例分析的预后因素。
机译:对FDG-PET,遗传标志物和临床病理危险因素对切除口腔鳞状细胞癌患者预后分层的最大标准化摄取价值的综合分析
机译:基于肺部切除外周鳞状细胞癌患者临床病理数据的预后因素。
机译:疼痛是与口腔鳞状细胞癌患者癌症生长模式和临床阶段相关的预后因素
机译:表皮生长因子受体和核因子κB通路对头颈部鳞状细胞癌患者的预后潜力及相关治疗策略。
机译:切除气管鳞状细胞癌的病理特征:基于59例分析的预后因素
机译:切除气管鳞状细胞癌的病理特征:基于59例分析的预后因素